1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends

Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

  • March 2016
  • 160 pages
  • BCC Research
Report ID: 326190

Summary

Table of Contents

The BCC Research report provides a comprehensive analysis of CNS biomarkers on a global basis. Its aim is to provide a range of information, from detailed product analyses within disease sub segments to overall industry trends, in order to quantify and qualify the market for products and services in the CNS biomarkers segment. Includes forecast through 2020.

Use this report to:

Examine leading and emerging competitors in the current worldwide CNS biomarkers market.
Investigate the introduction of combination therapies, which are expected to contribute substantially to market growth through the forecast period.
Assesses companies poised to introduce products during the forecast period and discuss how it will affect the competitive environment.
Examine the competitive environment with emphasis on how new products and technologies are influencing the current standard of care.

Highlights

The global CNS biomarker market should reach nearly $5.1 billion by 2020 from $3.1 billion in 2015, a compound annual growth rate (CAGR) of 10.4% from 2015 to 2020.
The discovery application market should reach over $3.3 billion by 2020 from over $1.9 billion in 2015, a CAGR of 11.7% from 2015 to 2020.
The drug development application market should reach $776 million by 2020 from $303 million in 2015, a CAGR of 20.7% from 2015 to 2020.

REASONS FOR DOING THE STUDY

For companies with an effective strategy, market opportunity awaits. Importantly, the ability to develop such a strategy begins where opportunity exists and ends with effective execution to capture profit from that opportunity.
The CNS biomarkers market presents the largest of all opportunities in representative disease sub segments. This study investigates one of the most important market drivers: the introduction of combination therapies, which are expected to continue to contribute substantially to market growth through the forecast period. This report analyzes emerging markets by disease segment.

Continued growth is expected in countries such as India, China, Brazil and Russia where a growing middle class is driving this growth. This report seeks to address and analyze the critically important areas of changing market dynamics, emerging players and technologies, strategies for accessing emerging markets, and specific disease segments and geographies in order to help companies allocate resources and make effective decisions.

SCOPE OF REPORT

Current and projected product forecasts during the forecast period (2014 to 2020) are discussed. New products approved in 2013 and 2014 by the U.S. Food and Drug Administration (FDA), and those products expected to be approved within the forecast period are discussed. Figures for 2015 are estimated, except where actual results have been reported.

The report includes analysis of leading and emerging competitors in the current worldwide CNS biomarkers market. Profiles of manufacturers of leading products as well as biotechnology companies with novel products in development are analyzed to define the specific product strategies employed. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment. The competitive environment is examined with a special focus on how new products and technologies are influencing the current standard of care. Detailed profiles are provided for current market leaders as well as companies with innovative products poised to advance within the forecast period.

Market figures are based on revenues at the manufacturers’ level and are projected at the 2015 dollar value. Inflation is not computed into the projection figures. Trends are assessed based on projected sales for existing products, new product introductions, expanded indications for existing products, and projected changes in the prevalence, diagnosis, and scripting rates for certain diseases.

Included in this report are forecasts by product, product category and company from 2015 through 2020. The study is arranged to offer an overview of the CNS biomarkers market accompanied by product, company, geography, and mechanism of action, with forecasts broken down and covered by geographic region or country. Virtually the entire globe is covered to include prevalence data for each disease sub segment.
In general, excluded from this report are over-the-counter (OTC) medications, and other consumables that do not require a physician’s prescription.

Sales figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies.
All market share data presented is on a global basis, unless specifically noted.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Cancer Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • $ 5795
  • Industry report
  • May 2017
  • by Transparency Market Research

Global Cancer Biomarkers Market: Overview Biomarkers are the substance or molecules found in blood, other body fluids or tissues which states the normal and abnormal condition of the body, biomarkers ...

Cancer Biomarker Market Analysis By Type (Breast, Prostate, Colorectal, Cervical, Liver, Lung Cancer), By Biomolecule (Genetic, Epigenetic, Metabolic, Proteomic), By Application, And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • May 2017
  • by Grand View Research

The global cancer biomarkers market is expected to reach a value of USD 33.7 billion by 2025, based on a new report by Grand View Research, Inc. Growing initiatives for development of drugs targeting novel ...

NASH Biomarkers Market Analysis By Type, By End-Use And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • July 2017
  • by Grand View Research

NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Analysis By Type (Serum, Hepatic Fibrosis, Apoptosis, Oxidative Stress), By End-Use (Pharma & CRO Industry, Hospitals, Diagnostic Labs, Academic Research ...


Download Unlimited Documents from Trusted Public Sources

Genomics Markets in France and China

  • July 2017
    5 pages
  • Genomics  

    Cytogenetic  

    Research And De...  

  • France  

    China  

View report >

Obesity Statistics in the UK

  • July 2017
    15 pages
  • Obesity  

    Biomarker  

  • United Kingdom  

    United States  

View report >

Genomics Industry in Denmark

  • July 2017
    7 pages
  • Genomics  

  • Denmark  

View report >

Related Market Segments :

Biomarker

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.